• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疼痛性骨转移瘤的管理

Management of painful bone metastases.

作者信息

Mercadante Sebastiano, Fulfaro Fabio

机构信息

Anesthesia & Intensive Care Unit - La Maddalena Cancer Center, University of Palermo, Palermo, Italy.

出版信息

Curr Opin Oncol. 2007 Jul;19(4):308-14. doi: 10.1097/CCO.0b013e3281214400.

DOI:10.1097/CCO.0b013e3281214400
PMID:17545792
Abstract

PURPOSE OF REVIEW

This review examines recent data on the pathophysiology and mechanisms of bone pain; it highlights the use of multiple and interdisciplinary treatments rather than sole use of traditional analgesics.

RECENT FINDINGS

Bone pain has been shown to have a unique pathophysiology. Recent experimental (animal) models have revealed that, parallel to increased bone destruction, ipsilateral spinal cord segments that receive primary input from the cancerous femur exhibit several notable neurochemical changes. These mandate the use of opioid doses sufficient to inhibit the observed nociceptive behaviours; these doses are greater than those required to alleviate pain behaviours of comparable magnitude generated by inflammatory pain. Several substances have been tested in this animal model.

SUMMARY

According to new preclinical data, treatment of bone cancer pain requires multidisciplinary therapies such as radiotherapy applied to the painful area along with systemic treatment (hormone therapy or chemotherapy) and supportive care (analgesic therapy and bisphosphonates). In some selected cases use of radioisotopes and other noninvasive or minimally invasive techniques may be useful in the management of metastatic bone pain. The treatment should be individualized according to the patient's clinical condition, life expectancy, and quality of life.

摘要

综述目的

本综述探讨了近期关于骨痛病理生理学和机制的数据;强调了采用多种跨学科治疗方法,而非单纯使用传统镇痛药。

近期研究发现

已证实骨痛具有独特的病理生理学。近期的实验(动物)模型显示,与骨破坏增加同时发生的是,接受来自癌性股骨初级传入的同侧脊髓节段呈现出一些显著的神经化学变化。这些变化要求使用足以抑制观察到的伤害性反应行为的阿片类药物剂量;这些剂量大于缓解由炎性疼痛产生的同等程度疼痛行为所需的剂量。在该动物模型中已对几种物质进行了测试。

总结

根据新的临床前数据,骨癌疼痛的治疗需要多学科疗法,如对疼痛部位进行放射治疗,同时进行全身治疗(激素治疗或化疗)以及支持治疗(镇痛治疗和双膦酸盐类药物)。在某些特定病例中,使用放射性同位素及其他非侵入性或微创技术可能有助于转移性骨痛的管理。治疗应根据患者的临床状况、预期寿命和生活质量进行个体化。

相似文献

1
Management of painful bone metastases.疼痛性骨转移瘤的管理
Curr Opin Oncol. 2007 Jul;19(4):308-14. doi: 10.1097/CCO.0b013e3281214400.
2
The management of painful bone metastases with biphosphonates and palliative radiotherapy: a retrospective evaluation of 372 cases.双膦酸盐和姑息性放疗治疗疼痛性骨转移:372例回顾性评估
J BUON. 2009 Apr-Jun;14(2):245-9.
3
Managing metastatic bone pain: the role of bisphosphonates.转移性骨痛的管理:双膦酸盐的作用。
J Pain Symptom Manage. 2007 Apr;33(4):462-72. doi: 10.1016/j.jpainsymman.2007.01.001.
4
Approaches to managing bone metastases from breast cancer: the role of bisphosphonates.乳腺癌骨转移的管理方法:双膦酸盐的作用
Cancer Treat Rev. 2005 Jun;31(4):303-11. doi: 10.1016/j.ctrv.2005.03.005. Epub 2005 Apr 26.
5
[Treatment of bone metastases with bisphosphonates].[双膦酸盐治疗骨转移]
Rev Med Suisse. 2006 Aug 9;2(75):1861-6.
6
Pharmacotherapy of bone metastases in breast cancer patients.乳腺癌患者骨转移的药物治疗
Expert Opin Pharmacother. 2008 Apr;9(6):937-45. doi: 10.1517/14656566.9.6.937.
7
Challenges in cancer pain management--bone pain.癌症疼痛管理中的挑战——骨痛
Eur J Cancer. 2008 May;44(8):1083-90. doi: 10.1016/j.ejca.2008.03.001. Epub 2008 Apr 23.
8
[Bone metastases pain in the elderly].[老年人骨转移疼痛]
Rev Med Suisse. 2009 May 20;5(204):1126, 1128, 1130 passim.
9
State of the art of palliative therapy.姑息治疗的现状。
Q J Nucl Med Mol Imaging. 2011 Aug;55(4):411-9.
10
Optimal management of metastatic bone disease.转移性骨病的优化管理。
Eur J Oncol Nurs. 2007;11 Suppl 2:S32-7. doi: 10.1016/j.ejon.2007.07.003. Epub 2007 Sep 4.

引用本文的文献

1
Systemic administration of Resolvin D1 reduces cancer-induced bone pain in mice: Lack of sex dependency in pain development and analgesia.D1 型 resolvin 全身给药可减轻小鼠癌性骨痛:疼痛发展和镇痛过程中无性别依赖性。
Cancer Med. 2024 Aug;13(15):e70077. doi: 10.1002/cam4.70077.
2
Treatment of Pelvic and Spinal Bone Metastases: Radiotherapy and Hyperthermia Alone vs. in Combination.盆腔和脊柱骨转移瘤的治疗:单纯放疗与热疗对比联合放疗与热疗
Cancers (Basel). 2024 Apr 22;16(8):1604. doi: 10.3390/cancers16081604.
3
Magnetic resonance-guided focused ultrasound versus percutaneous thermal ablation in local control of bone oligometastases: a systematic review and meta-analysis.
磁共振引导聚焦超声与经皮热消融在骨寡转移瘤局部控制中的比较:系统评价与荟萃分析
Radiol Med. 2024 Feb;129(2):291-306. doi: 10.1007/s11547-024-01780-4. Epub 2024 Feb 2.
4
Pain Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Ra: PARABO, a Prospective, Noninterventional Study.镭 223 治疗去势抵抗性转移性前列腺癌患者的疼痛结局:一项前瞻性、非干预性研究。
J Nucl Med. 2023 Sep;64(9):1392-1398. doi: 10.2967/jnumed.123.265557. Epub 2023 Jun 29.
5
Rac1/PAK1 signaling contributes to bone cancer pain by Regulation dendritic spine remodeling in rats.Rac1/PAK1 信号通路通过调控大鼠树突棘重塑参与骨癌痛。
Mol Pain. 2023 Jan-Dec;19:17448069231161031. doi: 10.1177/17448069231161031.
6
Mechanisms of cancer pain.癌痛的机制。
Front Pain Res (Lausanne). 2023 Jan 4;3:1030899. doi: 10.3389/fpain.2022.1030899. eCollection 2022.
7
Dexamethasone Coanalgesic Administration in Steroid Naïve and Steroid Non-Naïve Patients for the Prevention of Pain Flares after Palliative Radiotherapy for Bone Metastases.地塞米松在激素初治和非初治患者中经鼻给予预防骨转移姑息性放疗后疼痛发作的效果。
Pain Res Manag. 2022 Nov 28;2022:6153955. doi: 10.1155/2022/6153955. eCollection 2022.
8
Interventional Radiology in the Management of Metastases and Bone Tumors.介入放射学在转移瘤和骨肿瘤治疗中的应用
J Clin Med. 2022 Jun 7;11(12):3265. doi: 10.3390/jcm11123265.
9
State-of-the-art of minimally invasive treatments of bone metastases.骨转移瘤微创治疗的研究现状
J Bone Oncol. 2022 Mar 19;34:100425. doi: 10.1016/j.jbo.2022.100425. eCollection 2022 Jun.
10
Mechanisms, Diagnosis and Treatment of Bone Metastases.机制、诊断与骨转移治疗。
Cells. 2021 Oct 29;10(11):2944. doi: 10.3390/cells10112944.